Partner with ArcentLabs

Evidence-first for life-science R&D

Developing proprietary AI systems and integrating computational biology with experimental research to accelerate biological discovery and therapeutic development

ArcentLabs is a deep-tech biotechnology company developing uncertainty-aware computational systems for therapeutic discovery, bioprocess development and clinical research — helping scientists make better decisions before costly experiments, validation studies and trials.

Where we work

Therapeutic Discovery & Biological modeling

Computational models and discovery programs for prioritising biological hypotheses and therapeutic interventions before expensive validation.

Bioprocess Development

Clinical Research

Hybrid mechanistic and machine-learning systems for data-efficient experimental design and process optimisation.

Generative AI, predictive ML, structural biology, molecular design

Where we work

Computational R&D

Auditable AI for cohort quality, clinical-data enhancement, protocol design and more representative clinical development.

Research Programs

Lysosomal Repair Program

Therapeutic discovery · Parkinson's disease
A preclinical discovery program investigating pharmacologic potentiation of VPS13C-dependent lysosomal repair.

HostBridge

Virtual aged-tissue modelling
Uncertainty-aware prioritisation of geroprotective interventions before experimental validation.

We build with experimental and clinical partners

Adaptive bioprocess modelling
Data-efficient media and feed optimisation across mammalian cell lines and process contexts.

GEROTWIN